US President Trump has exempted Indian pharmaceuticals from new reciprocal tariffs, benefiting India’s pharmaceutical sector. This sector is vital for affordable medicines and economic stability, with the US market representing 30% of Indian exports.
Related Posts
India joins UN panel on big data for official statistics
India has joined the UN committee of experts on big data and data science for official statistics, marking a significant advancement in the country’s statistical […]
9 more ‘suspected’ GBS cases in Pune, high E Coli bacteria found near dam
The state health department in Pune has added nine suspected Guillain-Barré Syndrome (GBS) cases, bringing the total to 73 since January 9. Officials identify bacterial […]